Genetic Signatures Statistics

Total Valuation

Genetic Signatures has a market cap or net worth of AUD 147.60 million. The enterprise value is 112.57 million.

Market Cap	147.60M
Enterprise Value	112.57M

Important Dates

The last earnings date was Wednesday, November 20, 2024.

Earnings Date	Nov 20, 2024
Ex-Dividend Date	n/a

Share Statistics

Genetic Signatures has 227.08 million shares outstanding. The number of shares has increased by 15.25% in one year.

Current Share Class	n/a
Shares Outstanding	227.08M
Shares Change (YoY)	+15.25%
Shares Change (QoQ)	+30.11%
Owned by Insiders (%)	3.56%
Owned by Institutions (%)	52.81%
Float	193.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.80
PB Ratio	2.29
P/TBV Ratio	2.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.30
EV / Sales	8.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.30

Financial Position

The company has a current ratio of 10.04, with a Debt / Equity ratio of 0.02.

Current Ratio	10.04
Quick Ratio	8.76
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	-523.74

Financial Efficiency

Return on equity (ROE) is -34.34% and return on invested capital (ROIC) is -21.77%.

Return on Equity (ROE)	-34.34%
Return on Assets (ROA)	-19.69%
Return on Capital (ROIC)	-21.77%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.24
Inventory Turnover	1.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.22% in the last 52 weeks. The beta is 0.05, so Genetic Signatures's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	+23.22%
50-Day Moving Average	0.67
200-Day Moving Average	0.70
Relative Strength Index (RSI)	38.10
Average Volume (20 Days)	65,405

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genetic Signatures had revenue of AUD 13.77 million and -17.86 million in losses. Loss per share was -0.11.

Revenue	13.77M
Gross Profit	5.86M
Operating Income	-18.33M
Pretax Income	-17.86M
Net Income	-17.86M
EBITDA	-16.53M
EBIT	-18.33M
Loss Per Share	-0.11

Full Income Statement

Balance Sheet

The company has 36.25 million in cash and 1.22 million in debt, giving a net cash position of 35.03 million or 0.15 per share.

Cash & Cash Equivalents	36.25M
Total Debt	1.22M
Net Cash	35.03M
Net Cash Per Share	0.15
Equity (Book Value)	61.10M
Book Value Per Share	0.28
Working Capital	47.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.12 million and capital expenditures -1.98 million, giving a free cash flow of -12.10 million.

Operating Cash Flow	-10.12M
Capital Expenditures	-1.98M
Free Cash Flow	-12.10M
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross margin is 42.53%, with operating and profit margins of -133.14% and -129.74%.

Gross Margin	42.53%
Operating Margin	-133.14%
Pretax Margin	-129.74%
Profit Margin	-129.74%
EBITDA Margin	-120.05%
EBIT Margin	-133.14%
FCF Margin	-87.88%

Dividends & Yields

Genetic Signatures does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.25%
Shareholder Yield	-15.25%
Earnings Yield	-16.63%
FCF Yield	-8.20%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Genetic Signatures has an Altman Z-Score of 8.1.

Altman Z-Score	8.1
Piotroski F-Score	n/a